Markets › United States › NAS › PBLS

Parabilis Medicines Inc

NAS:PBLSHealthcarenasdaq_composite

$27.08+6.82%At closeAt close · Wed 21 Oct · ≈ AED 99.45 · Market cap $3.35B · Next earnings Wed 2 Dec

USD millions	FY2024	FY2025
Revenue	0.0	0.0
Cost of revenue	2.1	2.5
Gross profit	(2.1)	(2.5)
Research & development	100.7	125.0
Operating expenses	124.0	149.6
Operating income	(126.1)	(152.1)
Interest expense	1.5	1.5
Interest income	6.4	3.4
Pre-tax income	(117.9)	(145.9)
Income tax	0.0	0.0
Net income	(117.9)	(145.9)
EPS, basic (per share)	(1.37)	(1.58)
EPS, diluted (per share)	(1.37)	(1.58)
EBITDA	(124.0)	(149.6)
Depreciation & amortization	2.1	2.5
Weighted average shares (shares)	118,145,780	118,145,780
Weighted average diluted shares (shares)	118,145,780	118,145,780